Created by ghost123 In the post-treatment setting areas of enhancement can reflect post-treatment changes or tumor so the label has been renamed enhancing tissue.
Resection cavities can have variable signal characteristics depending on if the are new or old.
It does generally follow paradigm of 2021-2023 challenges but with changes relevant to the post-treatment setting.
Please see the Arxiv paper for more details
https://arxiv.org/abs/2405.18368
Jeff
Drop files to upload
Clarification on BRATS-2024 Adult Glioma Dataset page is loading…